Devonian Health Group (TSXV:GSD) EBIT : C$-0.88 Mil (TTM As of Jul. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Devonian Health Group EBIT?

Devonian Health Group's earnings before interest and taxes (EBIT) for the three months ended in Jul. 2024 was C$1.15 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jul. 2024 was C$-0.88 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Devonian Health Group's annualized ROC % for the quarter that ended in Jul. 2024 was 33.31%. Devonian Health Group's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jul. 2024 was 182.83%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Devonian Health Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jul. 2024 was -3.15%.

Devonian Health Group EBIT Historical Data

The historical data trend for Devonian Health Group's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Devonian Health Group EBIT Chart

Devonian Health Group Annual Data

Trend

Jun15

Jun16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

Jul24

EBIT

Get a 7-Day Free Trial

-3.61

-2.60

-2.51

-4.14

-0.85

Devonian Health Group Quarterly Data
	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24
EBIT	Get a 7-Day Free Trial															-0.75	-0.60	-1.14	-0.29	1.15

Competitive Comparison of Devonian Health Group's EBIT

For the Biotechnology subindustry, Devonian Health Group's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Devonian Health Group's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Devonian Health Group's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Devonian Health Group's EV-to-EBIT falls into.

Devonian Health Group EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jul. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.88 Mil.

Devonian Health Group (TSXV:GSD) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Devonian Health Group's annualized ROC % for the quarter that ended in Jul. 2024 is calculated as:

	ROC % (Q: Jul. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Apr. 2024 )	+	Invested Capital (Q: Jul. 2024 ))	/ count )
=	4.84 * ( 1 - 0% )	/	( (14.666	+	14.394)	/ 2 )
=	4.84	/	14.53
=	33.31 %

where

	Invested Capital		(Q: Apr. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	25.345	-	9.815	-	( 3.508	-	max(0, 11.892	-	12.756	+	3.508	))
=	14.666

	Invested Capital		(Q: Jul. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	30.733	-	14.025	-	( 9.863	-	max(0, 16.146	-	18.46	+	9.863	))
=	14.394

Note: The Operating Income data used here is four times the quarterly (Jul. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Devonian Health Group's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jul. 2024 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Jul. 2024 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Apr. 2024		Q: Jul. 2024
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	4.6	/	( ( (2.536 + max(-0.908, 0))	+	(2.496 + max(-6.023, 0)) )	/	2 )
=	4.6	/	( ( 2.536	+	2.496 )	/	2 )
=	4.6	/	2.516
=	182.83 %

where Working Capital is:

	Working Capital		(Q: Apr. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(8.118	+	0.205	+	0.584)	-	(9.815	+	0	+	0)
=	-0.908

	Working Capital		(Q: Jul. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(7.686	+	0.061	+	0.256)	-	(14.025	+	0	+	0.0010000000000012)
=	-6.023

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Jul. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Devonian Health Group's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Jul. 2024 )
	=	-0.88	/	27.957
	=	-3.15 %

Devonian Health Group EBIT Related Terms

Thank you for viewing the detailed overview of Devonian Health Group's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Devonian Health Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Devonian Health Group Inc (TSXV:GSD) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

DVHGF:USA

Address

360, Rue des Entrepreneurs, Montmagny, QC, CAN, G5V 4T1

Website

https://www.groupedevonian.com

Devonian Health Group Inc is operating in the pharmaceutical sector. It is engaged in the development and distribution of botanical drugs. The group is also involved in the development of value-added products for dermo-cosmetics. It has established a research effort focused on the anticipation of new solutions in the medical sector as well as in the cosmetic sector. The company's technology platform, The Supra Molecular Complex Extraction and Stabilization Technology provides a process of extraction, purification, stabilization, and conditioning of molecular complexes, as active botanical ingredients, from plants and algae. Its product portfolio includes pharmaceuticals like Thykamine, Pantoprazole, and Cleo-35; and cosmeceutical products like R-Spinasome and Purgenesis.

Devonian Health Group Headlines

No Headlines